Pre-earnings brief
Reports
Tue, Nov 3, 2026
Est. EPS
$0.19
Est. revenue
$3.9B
Implied move
±7.6%
EPS beat rate
50%
Koninklijke Philips N.V. (PHG) is a health care company that focuses on improving people's health through innovative medical technologies and solutions. With a market cap of $24 billion, Philips is significant in the health care equipment industry, especially as demand for advanced medical devices continues to grow amid global health challenges.
Last quarter
In Q3 2025, Philips reported an EPS of $0.22, which was significantly below the expected $0.36, resulting in a 40% surprise. The stock reacted positively, gaining 2.98% the following day despite the disappointing earnings.
EPS beat streak
0Q
EPS beat rate
50%
Avg EPS surprise
+11.00%
Avg 1-day reaction
+1.62%
Analysts expect Philips to report an EPS of $0.19 and revenue of $3.9 billion for Q4 2025, reflecting cautious optimism after a series of mixed earnings results.
Bull case
If Philips can exceed EPS expectations and show strong revenue growth, it may indicate a recovery in demand for its products, boosting investor confidence.
Bear case
Conversely, if Philips misses earnings expectations again, it could signal ongoing operational challenges, leading to further declines in stock price.
Key metrics to watch
EPS
$0.19Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.
Revenue
$3.9BRevenue figures will provide insight into the company's sales performance and market demand for its health care products.
The print will turn on these.
Q1
Will Philips achieve an EPS of at least $0.19?
This figure is critical as it will determine if the company can regain investor confidence after recent earnings misses.
Q2
What are the revenue figures for the health care segment?
Revenue performance in this key area will indicate market demand and the effectiveness of Philips' product offerings.
—
Est. EPS
$-0.50
Est. Rev
$257M
Impl. Move
±8.7%
Why consensus could be wrong
The consensus may underestimate Philips' potential for recovery, as recent product launches could drive unexpected demand.
Supporting evidence
The options market is pricing a move of 7.61%, suggesting uncertainty that could lead to larger swings than anticipated.
Philips has a history of surprising on the upside, with a 67% beat rate in recent quarters.
The stock has shown resilience after past earnings misses, indicating potential for recovery.
Key risk
If revenue from the health care segment falls below $3.8 billion, it could significantly undermine the bullish outlook.
Pre-commit to what would confirm each case.
The core debate this quarter revolves around whether Philips can stabilize its earnings and revenue after a series of disappointing results.
Bull confirmed if
An EPS of $0.19 or higher, coupled with revenue exceeding $3.9 billion, would confirm a positive outlook.
Bear confirmed if
An EPS below $0.19 and revenue below $3.8 billion would reinforce concerns about ongoing challenges.
What the market is pricing for the move.
Implied Move
±7.61%
Historical Avg
±10.1%
The options market is pricing in a potential move of about 7.61% in either direction following the earnings report, indicating uncertainty among investors.
Options are pricing ±7.6% while PHG has averaged ±10.1% over the last 8 prints — setup is pricing cheap.
ATM IV
0.3%
30d HV
17.5%
Smart-money positioning from the most recent 13F filings.
Institutional
5.41%
of float
Insider
0.00%
of float
Holders
420
institutions
Top Holders· as of Jun 2026
Exor N.V.
185,932,684 sh · $4.5B
18.92%
1.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Philips beats expectations, history suggests the stock could rise by around 1.31%, confirming a recovery narrative.
In line / cautious
If results are in line with expectations, the stock may experience a muted reaction as investors await more clarity on future guidance.
Miss
A miss could lead to a decline of about 1.53%, reinforcing concerns about the company's operational issues.
The lines on the call that would change the story.
Mondrian Investment Partners Ltd
8,067,528 sh · $194.3M
0.82%
3.5%
Dimensional Fund Advisors LP
4,340,691 sh · $104.6M
0.44%
-1.0%
Fiduciary Management, Inc.
3,459,961 sh · $83.4M
0.35%
-30.5%
Causeway Capital Management LLC
3,061,962 sh · $73.8M
0.31%
24.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.